Patent · US Active

MITF as a marker for predisposition to cancer

US9194003B2 · kind B2 · utility

0Cited by

0References

13Claims

0Family size

Assignees

INSTITUT GUSTAVE ROUSSY · FR
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
UNIVERSITE SOPHIA NICE ANTIPOLIS · FR

Inventors

Robert Ballotti · Nice, FR
Corine BERTOLOTTO · Nice, FR
Brigitte Bressac De Paillerets · Sceaux, FR
Mahaut De Lichy · Paris, FR
Fabienne Lesueur · Val-de-Reuil, FR

Key dates

Filing date	Dec 21, 2010
Grant date	Nov 24, 2015
Priority date	—
Expiry date	Dec 21, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to a mutant of MITF which is useful as a marker for predisposition to the development of cancer and to uses thereof in diagnosis and preventive treatments, sumoylation being reduced or absent in this mutant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.